(EMAILWIRE.COM, May 23, 2008 ) Denver, CO - LegalView, the number one site for everything and anything legal on the Internet, announced a recent update to its traumatic brain injury (TBI) information portal (http://brain-injury.legalview.com), which will now include causes of the debilitating injury. TBI is a serious injury that affects millions of Americans each year, some of which suffer from serious and life altering effects. Often, many individuals who have been involved in an accident where they suffered a TBI (http://brain-injury.legalview.com) go without treatment, which can have severe side effects. Individuals who feel they may have been involved in a TBI incident should contact a medical professional immediately as well as consult an experienced brain injury (http://brain-injury.legalview.com) law firm to learn about developing a lawsuit in which monetary compensation may be awarded, to help ease the difficulties with paying for the expensive medical bills often associated with TBI.
The new information on brain injury causes (http://brain-injury.legalview.com/brain-injury-causes.aspx) will detail ways in which TBI occurs in order for individuals to recognize and protect them from being involved in a TBI accident. TBI can have serious consequences ranging from memory loss and cognition side effects to motor skill loss to coma or amnesia. To learn more about the causes of TBI, visit http://brain-injury.legalview.com/brain-injury-causes.aspx to read the updated information.
Additionally, LegalView offers other recently updated information portals on several controversial prescription drugs including Chantix, Singulair and Digitek. Chantix, a smoking cessation aid, was first introduced to the market in May 2006 from Pfizer. In late 2007, nearly 400 reports from patients on the drug had been received by the U.S. Food and Drug Administration (FDA) regarding serious side effects that included depression, erratic behavior and suicidal thoughts and actions. The FDA issued a Public Health Advisory relating to the drug, though did not go so far as to issue a Chantix recall (http://chantix.legalview.com). However, nearly 3 million Americans had already been prescribed the medication.
Similar to the Chantix side effects are those of Singulair. Singulair is a prescription medication from Merck that was released in 1998. The drug is a preventative treatment for asthma and allergies that was discovered in early 2008 to have potential side effects including suicidal behavior among both adult and child patients. The FDA issued a statement saying it would review the Singulair risks (http://singulair.legalview.com) and proceed from there, although thousands of patients may potentially remain at risk.
In addition to the Chantix and Singulair portals, LegalView recently created the Digitek digoxin information portal with information regarding the heart tablet's serious risks for patients that include cardiac arrest and death. Digitek digoxin is prescribed to individuals suffering from irregular heartbeats, but after a manufacturing defect caused the pills to be produced with double the allotted dosage, the FDA issued a Class I Digitek digoxin recall (http://digitek-digoxin.legalview.com). Learn more about this and other legal issues at http://www.LegalView.com/.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.
This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited press release distribution service, go to http://www.emailwire.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: